Therapies for galactosemia: a patent landscape

Research output: Contribution to journalArticle

Original languageEnglish
JournalPharmaceutical Patent Analyst
DOIs
Publication statusPublished - 21 Apr 2020

Keywords

  • aldose reductase inhibitors
  • cataracts
  • galactose 1-phosphate uridylyl
  • transferase
  • GALT
  • inherited metabolic disease
  • leloir pathway
  • mRNA therapy
  • PI3K/Akt signalling
  • salubrinal
  • Type I galactosemia

Cite this